Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия
  • Бизнес
  • Functional Area
  • Дата Sort ascending
Длъжност Място Местоположение дивизия Бизнес Functional Area Дата Sort ascending
Vodja skupine kontrole kakovosti v QLS Velike Molekule / Vodja laboratorija Bioanalitika (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Септ. 27, 2024
(Senior) QA Operations Specialist Schaftenau Austria Operations Innovative Medicines Quality Септ. 26, 2024
Labortechniker / QC Analyst II (m/w/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Септ. 26, 2024
QC Specialist II (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Септ. 26, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Септ. 24, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 20, 2024
Quality Assurance Manager - QP/RP Amsterdam Netherlands Operations Innovative Medicines Quality Септ. 17, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 13, 2024
AS&T ekspert (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Септ. 09, 2024
Senior QC Specialist Kundl Austria Operations Innovative Medicines Quality Септ. 09, 2024
QC Specialist I - Raw Materials Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 05, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud France Operations Innovative Medicines Quality Септ. 03, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality Септ. 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Септ. 03, 2024
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich Schaftenau Austria Operations Innovative Medicines Quality Септ. 03, 2024
QC Specialist Tech Resources & Compliance Durham USA Operations Innovative Medicines Quality Септ. 03, 2024
QC Specialist I - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
Associate Manager - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
QA Specialist APQR INSURGENTES Mexico Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist – QOP Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Quality Control Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Септ. 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality Септ. 03, 2024
eCompliance Manager Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Expert - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
QA Compliance Expert – Reg CMC Facilitator Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
QC Analyst II. Basel (Land) Switzerland Operations Innovative Medicines Quality Септ. 03, 2024
Head of Quality Carlsbad USA Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Quality Manager GCP / PV Hyderabad (Office) India Development Innovative Medicines Quality Септ. 03, 2024
Specialist Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Септ. 03, 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality Септ. 03, 2024
QC Analyst Sasayama Japan Operations Innovative Medicines Quality Септ. 03, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Юни 04, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България